Skip to main content
padlock icon - secure page this page is secure

Oral Sodium Cromoglycate in the Management of Atopic Dermatitis in Children

Buy Article:

$36.50 + tax (Refund Policy)

Atopic dermatitis (AD), a common, multifactorial, and extremely complex disorder, should be examined from various points of view, and it requires all the skill a physician can gather because it can be a challenge for pediatricians, dermatologists, and allergists. The role of dietary factors in AD has long been a subject of controversies, and several investigators have demonstrated the effectiveness of elimination diets in the management of AD. The treatment of choice for AD due to food sensitivity (FS) is the elimination of the offending food(s). This can be easily achieved when the child is allergic to foods that are not common items in the diet or when the offending food is not an important nutrient. Problems arise when the child is allergic to food(s) common in the diet and/or that have a high nutritional value, SCG, the salt of a bis-chromone carboxylic acid, has been shown to be of some efficacy in the prophylaxis of bronchial asthma, allergic rhinitis, and other disorders associated with mast cell degranulation, such as mastocytosis. We reviewed 12 papers on the use of SCG in the management of AD children, which included 281 children aged 0.5 to 15 years. Analysis of the studies shows that five were carried out in the open, one in the single-blind, six in the double-blind fashion. Four out of five open trials yielded positive results, that is, SCG was effective in the management of AD. The double-blind studies were positive in three cases and negative in three. The only trial with doubtful results was conducted in the open fashion.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Publication date: September 1, 1991

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more